* Significantly smaller than untreated controls, ** significantly smaller than BCG SQ and untreated control

Figure 3: Number of viable bacteria (CFU/mL) at necropsy in lung and spleen tissues after bacterial challenge of guinea pigs immunized with different BCG formulations by different routes (average ± std deviation, n=6).